GENE ONLINE|News &
Opinion
Blog

Series C Funding
China’s Neurophth Snags $63 Million in Series C to Boost Ophthalmic Gene Therapy Portfolio
2021-11-25
Taiwan’s Acepodia Closes $100 Million Series C to Accelerate Cancer Assets
2021-11-22
South Korea’s D&D Pharmatech Secures $51M Series C, Eyes 2022 IPO
2021-10-20
Allay Therapeutics Raises $60 Million to Finance its Non-Opioid Pain Management Platform
2021-09-16
Japanese Biotech Raises $37 Million in Series C to Develop Stem Cell Therapy for Heart Failure
2021-06-13
Oculis Raises $50 Million to Push Ophthalmic Portfolio and Expand International Foothold
2021-05-06
Arch Oncology Secures $105 Million in Funding for Advancing Anti-CD47 Therapy
2021-04-29
Monte Rosa Bags $95 Million Series C Funding to Advance Protein Degraders
2021-03-14
Massachusetts Cancer Startup to Fund Mission of Drugging the Undruggable with $107M Series C Round
2021-03-07
Tenaya Raises $106 Million Series C Round To Fight Heart Disease
2021-03-04
Clover Biopharmaceuticals Raises $230 Million to Expand Trimer-Tag Technology
2021-02-28
AI Powered Startup XtalPi Announces 300 Million Series C Funding
2020-09-30
Investors Back Seattle-Based Startup’s Novel Immuno-Oncology Program Targeting Solid Tumors
2020-09-26
Freenome Receives $270 Million Funding for Early Cancer Detection
2020-08-27
Weekly Top 5 in China (0217-0223)
2019-02-22
LATEST
Novel RAGE Antagonist Stirs Hopes for Countering Diabetic Complications
2021-12-07
AstraZeneca Blocks Private Equity Buyout of Swedish Pharma Sobi
2021-12-06
Coherent Biopharma, WuXi STA Collab Takes a Crack at Peptide-Drug Conjugates
2021-12-06
How CDMOs are Restructuring the Biopharma Landscape – An Interview with Bobby Sheng
2021-12-06
BeiGene launches IPO on Shanghai’s STAR market to raise $3B
2021-12-03
Novartis, UCB Take Aim at Parkinson’s Disease Under $1.65 Billion Collab
2021-12-03
Atara Biotherapeutics’ First-In-Class Allogeneic T-Cell Therapy Accepted for EMA Review
2021-12-02
EVENT
2021-12-13
63rd ASH ANNUAL MEETING AND EXPOSITION
Georgia, USA
2021-12-28
BIOHK2021
Hong Kong, China
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!